StockWatch
·

HERO MOTOCORP LTD. Q2 FY27 Results

HEROMOTOCOQ2 FY27 Results
Filing
Result:Good· Market: Down#Margin squeeze

Outlook: Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue15.0K14.1%22.5%
Total Income15.2K11.7%21.8%
Expenditure13.2K13.8%25.0%
PBT1.9K1.1%3.7%
Net Profit1.9K31.2%40.9%
OPM13.34%0.04pp1.92pp
NPM12.26%1.82pp1.66pp
EPS92.9931.7%42.2%
View full financials

Revenue grew a strong 22.5% YoY on festive/GST-cut tailwinds and PAT rose 40.8%, but OPM fell ~190bps (15.3%→13.3%) and PBT grew only ~4%, so the bottom-line beat was aided well beyond core operating performance, keeping this a healthy but not standout quarter for the sector.

HERO MOTOCORP · Q2 FY27 · THE VERDICT

Record volume, but the profit was borrowed

Reported earnings jumped 41%, but equity consolidation gains masked a 5% operational profit slowdown. The bigger miss: EBITDA margins compressed to 13.4%, forcing management to defer the 14-16% target to an unspecified 'medium-term.'

03 Nov 2026 · 6 min read

On the surface, Hero Motocorp's Q2 results look exceptional — PAT up 41%, revenue up 23%, volume growth broad-based across geographies and categories. But two numbers buried in the quarter tell the real story. The first: standalone operational profit rose just 5%. The second: EBITDA margins compressed to 13.4%, 60 basis points below the company's own 14-16% guidance, a miss management reaffirmed but deferred to an unspecified 'medium-term' recovery. This is the quarter when the market's enthusiasm met the reality of commodities and execution.

Reported PAT

₹1,861 Cr

+40.8% YoY

Equity consolidation gain

₹397 Cr

21% of reported PAT

Adjusted PAT

~₹1,464 Cr

+5% YoY (organic)

EBITDA margin

13.4%

vs 14-16% guided

Where the headline profit came from

Hero reported consolidated PAT of ₹1,861 Cr, an eye-catching +40.8% YoY. But ₹397 Cr of that gain — 21% of the total — came from equity consolidation accounting for its VIDA electric scooter associate, not from operating the motorcycles and scooters the business is built on. Strip that out, and standalone operational PAT was ₹1,464 Cr, up a modest 5% YoY. The consolidated number made headlines; the operating number is what matters for next quarter.

Q2 FY27 PAT, ₹ Cr
0694.771,389.552,084.321,861Reported397Equity gain1,464Adjusted
The consolidation gain is 21% of reported PAT. Adjusted profit is the organic benchmark.

What management claimed vs. what the numbers show

Management claims on the call, graded against delivered results

Revenue growth 21% YoY, reflecting volume gains and mix premiumization

What the numbers show

Consolidated revenue ₹14,971 Cr (+22.5% YoY). Volume +10.5%; mix uplift ~5% from scooter/EV/ICE rebalance.

Verdict

Supported (actually 22.5%, slightly better than stated)

PAT grew 41% YoY to ₹1,861 Cr despite commodity headwinds

What the numbers show

Reported ₹1,861 Cr (+40.8% YoY) includes ₹397 Cr equity gain. Standalone operational profit only +5%.

Verdict

Supported on headline; materially misleading without adjustment

EV capacity doubled to 30,000 units/month by September; scaling to 45,000 by Q4

What the numbers show

Started at 15,000/month FY26 end, confirmed at 30,000 Sep 2026. 45,000/month Q4 target and 80,000 by Q2 FY28 committed.

Verdict

Supported; roadmap extended to 80k (upgrade)

~70% EV portfolio PLI certified in Q2; 100% by October 2026

What the numbers show

₹63 Cr PLI accrual in Q2 (~6.3% of ₹1,000 Cr EV revenue). Oct 2026 100% certification on track.

Verdict

Supported

EBITDA margin stable at 13.4%, maintaining 14-16% medium-term target

What the numbers show

Q2 EBITDA ₹1,968 Cr (13.4% margin). Below 14-16% range. Reaffirmed but with 'medium-term' qualifier; recovery deferred.

Verdict

Overstated. Margin is below guidance; recovery timeline pushed out.

What changed on this call

EV capacity roadmap extended. Hero was guiding to 45,000 units/month by Q4 FY27. On this call, management committed to an additional step: 80,000 units/month by Q2 FY28. That's a doubling of capacity from Sep's 30,000 within six months — ambitious but backed by demonstrated execution and strong demand (dealer inventory at a 1-day cycle, manufacturing capacity-constrained). This is a credibility upgrade on the EV thesis. EBITDA margin recovery timeline shifted. The 14-16% target was reaffirmed, but the language changed. Where prior guidance implied near-term recovery, management now tied it to 'medium-term' normalization of commodity inflation. Gross margin compressed 30 basis points QoQ despite 21% revenue growth — a warning that cost headwinds are structural, not cyclical. The recovery is now conditional on global commodity price stabilization, with no committed timeline.

The bull-bear ledger
  • Volume growth +22.5% in revenue; +10.5% in wholesale volume

  • Mix-driven revenue uplift (+5% on top of volume); ICE scooters, EV, premium all gaining

  • EV capacity expansion on track: 30k achieved, 45k by Q4, 80k by Q2 FY28

  • Parts/accessories business +27% YoY; high-margin differentiator

  • Consolidated PAT +41% masks +5% organic profit; equity gain inflated headline

  • Gross margin compressed 30 bps QoQ despite 21% revenue growth

  • EBITDA margin 13.4% vs 14-16% guided; recovery deferred to vague 'medium-term'

  • Premium segment penetration low; launches (Xtreme 160/250) slow to gain traction

  • Export revenue +19% YoY vs 23% consolidated; geopolitical headwinds (Colombia earthquake, Bangladesh)

  • EV gross margin turned positive in Q2; unit economics improving via pricing and LEAP savings

Risks, ranked by how much they should concern a holder

Risk landscape for Hero from here

Commodity cost inflation eroding margins faster than pricing can absorb

High

Q1+Q2 inflation ~5.5% cumulative across steel, aluminum, rubber, fuel. Hero recovered only ~2.5% through price hikes and cost actions, leaving a 300 bp structural gap. Gross margin compressed 30 bps QoQ despite 21% revenue growth. EBITDA margin now 13.4% vs 14-16% target. Recovery is tied to global commodity normalization — outside management control. If inflation persists, margin recovery stalls.

Export market concentration (Colombia ~25%) exposed to geopolitical shocks and natural disasters

High

Q2 Ecuador earthquake hit Latin America (Colombia ~25% of Hero's exports), and Bangladesh fuel crisis disrupted supply. Global business revenue grew only +19% vs 23% consolidated. Export wholesale was negative in Q2. While Hero expects recovery in Q3, further Latin American shocks or supply-chain disruptions in Bangladesh could reignite headwinds. Unhedged 25% concentration in one country is material.

Premium motorcycle segment growth lagging product investment and capacity spending

Medium

Hero launched Xtreme 160/250 and invested in Premia dealer network (150 stores), yet premium segment penetration remains <10% of portfolio. Xpulse is strong (~35% adventure share), but broader motorcycle market is underpenetrated. If premium launches don't gain traction by H2 or dealer network ramp slows, Hero's mix-uplift story suffers and margins remain pressured.

EBITDA margin recovery timeline vague; deferred from near-term to unspecified 'medium-term'

Medium

Hero reaffirmed 14-16% EBITDA margin but tied recovery to commodity normalization and LEAP savings, both uncertain timelines. Current 13.4% is a material miss on prior implicit expectation. Each quarter margins stay below 14%, earnings growth faces headwinds and valuation re-rating risk. Street expected recovery by Q3; now it's Q3+ and conditional on macro factors.

EV capacity expansion ahead of actual demand; scooter market penetration saturation risk

Low

Hero plans 80,000 EV units/month by Q2 FY28 and targets 27% blended EV share by FY29, but industry EV penetration is only ~14% (Oct 2026). Risk of overbuilding if category growth decelerates or competitors enter aggressively. However, Hero's dealer inventory is tight (1-day cycle), current demand strong, and scooter market underpenetrated in rural India. Over-capacity risk is deferred, not imminent.

How the street is positioned

Price action: the market's own verdict on the print. Hero announced results on Oct 28 at ₹5,322.5 (pre-result close). By day 1, the stock fell 4.09%; by day 3, it was down 2.43% cumulative from the announcement. That sell-off, though not catastrophic, reflects investor disappointment on two counts: the margin miss (13.4% vs 14-16% guidance) and the earnings quality (reported +41% PAT sounds great until you adjust for the ₹397 Cr equity gain, leaving only +5% organic). The market had priced in near-term margin recovery; reframing recovery as 'medium-term' is a reset of expectations downward.

Valuation and drawdown. At ₹5,193 (as of Nov 2), Hero is -18.71% off its all-time high of ₹6,388.5 but trades above its 20-day SMA of ₹5,103.65. It sits below both the 50-day and 200-day SMAs (both ~₹5,272), signaling a stock in consolidation after a significant drawdown. The stock is +11.16% above its 52-week low but still 18.7% below ATH. A -18.7% drawdown from ATH typically signals either (a) genuine repricing of growth assumptions, or (b) oversold positioning. Hero's drawdown is driven by margin pressure, not by a growth collapse. If EBITDA margin recovery credibly accelerates in H2, the stock could re-rate higher; if it stalls, further downside is possible.

Ownership and flows. FII ownership stands at 31.09% (FY27 Q1), down marginally 6 basis points QoQ. DII ownership is 24.36%, down 42 basis points QoQ. Promoter stake flat at 34.73%. The slight trimming by both FII and DII in the quarter suggests cautious positioning heading into the earnings call — a signal that institutions were de-risking before the result. Post-result, the ownership data is not yet updated, but the sell-off and continued consolidation below the 50/200 SMAs suggest foreign and domestic institutions are holding rather than aggressively buying the dip. Hero has room to re-attract flows if margin recovery gains credibility or export recovery materializes.

The honest read

Hero Motocorp is executing on volume and capacity expansion — the +22.5% revenue, +10.5% wholesale, and doubling of EV capacity to 30k/month are genuine. But the quarter revealed a profitability challenge that management has not yet solved: commodity inflation is eroding gross margins faster than pricing power or cost programs can offset. At 13.4%, EBITDA margin sits 60 basis points below guidance, and the path back is unclear and deferred to an unspecified 'medium-term.' The reported PAT beat was an optical illusion (equity gain did the heavy lifting), and organic profit growth of +5% is pedestrian for a company guiding 22%+ revenue growth. This is not a broken business — volume growth, EV scaling, and parts/accessory momentum are credible. But it is a business facing structural near-term headwinds (commodities, premium segment traction, export concentration) that the market is right to discount. The stock's -4% day-1 reaction was justified; the -18.7% drawdown from ATH suggests fair repricing of near-term earnings power. The key to re-rating higher is a credible margin recovery path — either via commodity price stabilization (exogenous) or via accelerated cost reduction and mix improvement (endogenous). Until that is proven, expect consolidation.

What to watch next
  • 1 · Q3 EBITDA margin trajectory

    Management guided for margin stability in Q3 despite continued commodity volatility. If margins hold at 13.4% or improve, the LEAP program is working. If they compress further, the 14-16% recovery timeline gets pushed back. This is the single most important metric to track.

  • 2 · Premium segment traction and Premia network ramp

    Xtreme 160/250 launches and the Premia dealer network (150 stores) are aimed at restoring mix uplift. Q3 and Q4 results will show whether dealer absorption is accelerating or if premium remains a drag. This determines whether Hero can maintain its 5% mix uplift.

  • 3 · Export recovery post-geopolitical shock

    Colombia and Bangladesh should stabilize by Q3/Q4. Global business revenue growth back to 23%+ (in line with consolidated) would prove export headwinds are temporary. If it stays at +19% or falls further, the concentration risk is more durable.

This is not a quarter of step-change risk or broken momentum — Hero's volume story is real and EV positioning is strong. It is a quarter of deferred margin recovery and reset expectations on near-term profitability. The market was right to sell, right to stay cautious, and right to position Hero in consolidation mode until commodities or costs move decisively. The number to track from here is organic (adjusted) EBITDA margin progression in Q3. If it climbs toward 14% or higher, the floor is set and re-rating can follow. If it stays at 13.4% or compresses, the bear case strengthens and further downside is possible. Volume growth is in the bag; margin recovery is now the whole debate.

Informational and educational content only. Not investment advice.